Health Robotics Announces Successful Transition to new and Distinctively Superior Distribution Channels in North America

BOZEN, Italy, February 11 - Health Robotics today announced the successful completion of the
transition from its prior sales and support channels in North America to
McKesson and Health Robotics Canada Inc., with triple digit growth in sales
and installations, renewal of North American customers' commitment to Health
Robotics' world-leading and revolutionary products, and greatly improved
customer satisfaction.

"I'm very satisfied with our progress since last Summer - we decided to
terminate for cause the prior underperforming and inept distribution and
service channels in North America - and also with the fact that we have
accomplished so much more over the last 6 months than in the prior 3 years
combined, stated Werner Rainer, Health Robotics' CEO.

The first area that Health Robotics and its 2 new North American partners
set to rectify in August 2009 was the service personnel hiring and training,
the creation of a North American spare parts depot, and the organization of a
customer help desk, all lacking from prior distributors, in direct and
material breach of their service obligations. Since last Fall, we have turned
the corner on installations as confirmed by the CytoCare implementation at
the University of Pennsylvania Hospital and the renewed commitment to
CytoCare by the University of Colorado Hospital and other key academic
medical centers in America.

"I want to congratulate McKesson for the commitment they showed to
service and support by devoting more than 15 FTEs to multiple months of both
classroom and field training, culminating on February 5th with the hand-over
to McKesson of all CytoCare service and support activities in North America.
McKesson devoted in only 6 months over 100 times more hours to installation
and training than all our prior distributors combined in the prior 3 years,
culminating with the results achieved at Brigham and Women's Hospital which
may be witnessed at www.health-robotics.com/en/customers/ and that
were showcased February 8th on ABC News-Boston Channel, an example of the
high level of customer satisfaction once the prior distributors were fired,"
continued Mr. Rainer.

The next area (after service) that Health Robotics and its 2 new North
American partners set to significantly improve was to expand business
development activities. Starting with the December 2009 ASHP Midyear
symposium in Las Vegas, our 2 new North American distributors have generated
enough new contractual relationships in only 2 months to permit at least 50
new installations in 2010, over ten times more units in only 1 year than the
prior 3 years combined installations of the now-terminated prior distribution
channels. With the rest of 2010 still ahead of us, this is an unbelievable
achievement.

"Although we still have a lot of work ahead of us in North America,
including the optimization of new partners for TPNstation & the I.V. Room of
the Future, we have now demonstrated with results what we suspected in prior
years about the unprecedented ineptitude of our prior distribution channels,
blaming everyone else for their own shortcomings in frivolous lawsuits
against third parties [none against Health Robotics], including legal threats
to their own American hospital customers. It made no sense to us in prior
years that while our products received worldwide accolades, North America's
feedback was so different. It is very rewarding now to see how positively the
same American hospitals perceive our products after they no longer have to
deal with our prior distributors. Later this month we will begin to announce
the complete list of our 2 new partners' 2010 installations of CytoCare,
i.v.STATION, & i.v.SOFT", stated Mr. Rainer.

About Health Robotics:

Health Robotics is the undisputed global leading supplier of
life-critical intra-venous Medication Admixture robots, providing healthcare
facilities in 4 continents with robotics technology and software automation
solutions. Its world-leading solutions CytoCare(TM) [hazardous IVs],
i.v.STATION(TM) [non-hazardous IVs], i.v.SOFT(TM) [workflow engine for manual
compounding], TPNstation(TM) [totally-automated parenteral nutrition] have
and will greatly contribute to ease hospitals' growing pressures to improve
patient safety. Through the effective and efficient production of sterile,
accurate, tamper-evident and ready-to-administer IVs, Health Robotics helps
hospitals to eliminate life-threatening drug-exchange errors, to decrease
other medication mistakes and sterility risks, to work more efficiently, to
increase throughput, to reduce waste and controlled substances' diversion, to
contain costs, and to reduce the gap between rising patient volume/acuity and
scarce nursing and pharmacy staff. For more information, please visit
www.health-robotics.com

    For additional information, please contact:

    Health Robotics
    Gaspar G. DeViedma,
    Executive V.P., General Counsel, and Member of the Board of Directors
    Italy: +39-346-963-4934
    USA: +1-609-980-7976
    Canada: +1-289-470-1456
    Malaysia: +60-321-848-223
    gaspar.deviedma@health-robotics.com

For additional information, please contact: Health Robotics, Gaspar G. DeViedma, Executive V.P., General Counsel, and Member of the Board of Directors, Italy: +39-346-963-4934, USA: +1-609-980-7976, Canada: +1-289-470-1456, Malaysia: +60-321-848-223 gaspar.deviedma at health-robotics.com